Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- COMMENTARY 3 atricles
July 3, 2006
- Toyama Chemical Initiates PI Trial of Anti-RA Drug T-5224
July 3, 2006
- Average Wage Hike in Pharma Industry Higher Than All-Industry Average: Survey
July 3, 2006
- Bayer Initiates PIII for Antithrombosis Drug Rivaroxaban
July 3, 2006
- Bayer Succeeds in Taking Over Schering AG
July 3, 2006
- SEMINAR
July 3, 2006
- BUSINESS NEWS IN BRIEF
July 3, 2006
- R&D NEWS IN BRIEF
July 3, 2006
- SEMIANR
July 3, 2006
- Wyeth Celebrates 100 Years of Vaccine Leadership
July 3, 2006
- Combined Income-Outlay Reform Proposal Calls for Review of Range of Health Insurance Benefits
July 3, 2006
- MEDICAL DEVICE NEWS IN BRIEF
July 3, 2006
- Industry Prepared to Pay More Feesto Increase Number of Reviewers: Dr Aoki
July 3, 2006
- REPORT
July 3, 2006
- Korosho Has Budget to Conduct Market Price Survey This Year: HIB Official
July 3, 2006
- TOPICS 2 articles
July 3, 2006
- Ryukaikon Resumes Discussions
July 3, 2006
- Concern Expressed about Qualifications of New "Registered Drug Sellers"
July 3, 2006
- REGULATORY NEWS IN BRIEF
July 3, 2006
- Sales of OTC Smoking Cessation Aids to Grow in 2006: Fuji Keizai
July 3, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…